Skip to main content

** FILE ** A women leaves the Eli Lilly and Company campus in an Indianapolis file photo from April 18, 2006.

MICHAEL CONROY/AP

For the past three years, Eli Lilly and Co. traded within a horizontal trading range between $32.50 and $38 and then in a higher range between $35 and $39. This price action produced a bullish technical pattern known as a Duplex Horizontal (dashed lines). The recent rise to $42.03 (A) signalled the breakout from this formation and the start of a new major up-leg. Only a decline below about $37.50 would be negative.

Point & Figure measurements provide targets of $44 and $49. The large Duplex Horizontal pattern (dashed lines) supports higher targets.

Monica Rizk is the senior technical analyst for Phases & Cycles Inc. ( www.phases-cycles.com). Ron Meisels is a contributor to the www.NA-marketletter.com website. They may hold shares in companies profiled. Please see the site for a glossary.

Story continues below advertisement

Chart source: www.decisionplus.com

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Discussion loading ...

Cannabis pro newsletter